Generate Life Sciences completed the acquisition of Cell Care from CPE Capital.

Generate Life Sciences, a life sciences company, completed the acquisition of Cell Care, a tissue bank and cord blood company, from CPE Capital, a private capital manager. Financial terms were not disclosed. "As part of Generate, we will collaborate with Generate's scientific team to support the exciting therapeutic applications for newborn stem cells and deliver great value to the thousands of families who have banked their children's stem cells," Brent Dennison, Cell Care Chief Executive Officer.